These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28541516)

  • 1. Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.
    Fleckenstein JM
    J Infect Dis; 2017 Jul; 216(1):1-3. PubMed ID: 28541516
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization.
    Zhang C; Iqbal J; Gómez-Duarte OG
    Vet Microbiol; 2017 Apr; 202():90-100. PubMed ID: 26878971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
    Walker RI
    Vaccine; 2015 Feb; 33(8):954-65. PubMed ID: 25482842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
    Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of enterotoxigenic Escherichia coli genomics for vaccine development.
    Sjöling Å; von Mentzer A; Svennerholm AM
    Expert Rev Vaccines; 2015 Apr; 14(4):551-60. PubMed ID: 25540974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
    Xia P; Meng X; Zhu G
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterotoxigenic Escherichia coli: advances in technical and laboratory aspects of research and development of vaccines.
    Wkly Epidemiol Rec; 2008 Mar; 83(10):92-5. PubMed ID: 18326111
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity of a Multivalent Vaccine Candidate against piglet diarrhea caused by enterotoxigenic Escherichia coli (ETEC) in a pig model.
    Zhang H; Xu Y; Zhang Z; You J; Yang Y; Li X
    Vaccine; 2018 Jan; 36(5):723-728. PubMed ID: 29287679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.
    Tobias J; Svennerholm AM; Holmgren J; Lebens M
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1355-65. PubMed ID: 20405124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccine-adjuvant combination successful against bacterial diarrhea.
    Hum Vaccin Immunother; 2014; 10(12):3428. PubMed ID: 26052587
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
    Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
    Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress toward an enterotoxigenic Escherichia coli vaccine.
    Svennerholm AM; Lundgren A
    Expert Rev Vaccines; 2012 Apr; 11(4):495-507. PubMed ID: 22551034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.
    Walker RI; Wierzba TF; Mani S; Bourgeois AL
    Vaccine; 2017 Dec; 35(49 Pt A):6775-6782. PubMed ID: 28987444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.
    Fleckenstein JM; Rasko DA
    Methods Mol Biol; 2016; 1403():363-83. PubMed ID: 27076141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of vaccine research and development for enterotoxigenic Escherichia coli.
    Bourgeois AL; Wierzba TF; Walker RI
    Vaccine; 2016 Jun; 34(26):2880-2886. PubMed ID: 26988259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.